Recordati Rare Diseases Opens a New Office in China

On May 18th, the China-Italy Chamber of Commerce (CICC) was invited to participate in the opening ceremony of the new office of Recordati (Beijing) Pharmaceutical Co., Ltd. (RRD China), a member of the CICC.

Over the past 2 years, the RRD China team has been striving in China to introduce and commercialize innovative products in the Chinese market, expanding the accessibility and affordability of its treatments to benefit more Chinese patients suffering from rare diseases.

With the opening of the new office and the continuous growth of the team, RRD China aims to become a long-term strategic hub for Recordati group to cover the Chinese market, allowing it to concentrate on its long-term development of rare disease treatments and products, and further enhance the global competitiveness of the organization.